What does APOTHEEK SLUIZEKEN GENT do?

APOTHEEK SLUIZEKEN GENT is a pharmacy in Gent. Private Limited, started on 10 August 2011, 1 establishment.

What is the address of APOTHEEK SLUIZEKEN GENT?

The registered office of APOTHEEK SLUIZEKEN GENT is located at Sluizeken 13, 9000 Gent.

Is APOTHEEK SLUIZEKEN GENT still active?

Yes. According to the CBE (29 October 2026) APOTHEEK SLUIZEKEN GENT is active, legal situation “Normale toestand”, started on 10 August 2011.

Is APOTHEEK SLUIZEKEN GENT registered on Peppol?

Yes, APOTHEEK SLUIZEKEN GENT is registered on the Peppol network with ID 0208:0838581925.

What is the enterprise number of APOTHEEK SLUIZEKEN GENT?

The enterprise number of APOTHEEK SLUIZEKEN GENT is BE0838581925.

When was APOTHEEK SLUIZEKEN GENT founded?

APOTHEEK SLUIZEKEN GENT was founded on 10 August 2011.

Who are the directors of APOTHEEK SLUIZEKEN GENT?

According to the 2025 annual accounts, the directors of APOTHEEK SLUIZEKEN GENT are: Malinga BV, Groep DF BV.

Is APOTHEEK SLUIZEKEN GENT a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 10 August 2011; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did APOTHEEK SLUIZEKEN GENT make in 2025?

APOTHEEK SLUIZEKEN GENT posted a profit after taxes of € 31,126 in financial year 2025.

What is the revenue of APOTHEEK SLUIZEKEN GENT?

As a small company, APOTHEEK SLUIZEKEN GENT is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 266,143.

How much does an employee at APOTHEEK SLUIZEKEN GENT earn?

The average wage cost per full-time employee at APOTHEEK SLUIZEKEN GENT was € 66,700 in 2025: staff costs of € 180,074 for 2.7 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK SLUIZEKEN GENT have?

According to the 2025 annual accounts, APOTHEEK SLUIZEKEN GENT has 2.7 full-time equivalents (FTE).

APOTHEEK SLUIZEKEN GENT (Private Limited) - Gent

Dossier APOTHEEK SLUIZEKEN GENT, printed on 29 October 2026 from databakkes.be/en/0838581925/apotheek-sluizeken-gent. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Shrinking team NBB

FTE fell two years in a row, from 3.3 to 2.7.
Board fully replaced NBB

No director from three years ago is still active according to annual account 2025.

Financials

Financial year 2025

APOTHEEK SLUIZEKEN GENT from Gent, company number BE0838581925, closed financial year 2025 with a result of € 31,126 after tax. For that financial year APOTHEEK SLUIZEKEN GENT recorded a gross margin of € 266,143 and equity of € 29,196. Compared with financial year 2024, the result moved from € 67,627 to € 31,126. The company is profitable. The buffer shrank hard: equity is 89 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 9, 2026.

What it is worth Shrank hard

€ 29,196

▼ 89% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 31,126

▼ 54% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 110,756

▼ 5% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 259,725 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

2.7

▼ 0.4 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 180,074

▼ 11% vs 2024

€ 66,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 8,583

▼ 50% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 237,748

▲ 103% vs 2024

€ 55,222 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 155,739

▼ 6% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 15,371

▼ 55% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 314,340 Gross margin 2022: € 314,340 First fiscal year in the series	€ 312,150 Gross margin 2023: € 312,150 ▼ 1% vs 2022 (€ 314,340) Unfavourable step	€ 330,664 Gross margin 2024: € 330,664 ▲ 6% vs 2023 (€ 312,150) Favourable step	€ 266,143 Gross margin 2025: € 266,143 ▼ 20% vs 2024 (€ 330,664) Unfavourable step	▼ 20%
Profit after taxes	€ 72,378 Profit after taxes 2022: € 72,378 First fiscal year in the series	€ 57,979 Profit after taxes 2023: € 57,979 ▼ 20% vs 2022 (€ 72,378) Unfavourable step	€ 67,627 Profit after taxes 2024: € 67,627 ▲ 17% vs 2023 (€ 57,979) Favourable step	€ 31,126 Profit after taxes 2025: € 31,126 ▼ 54% vs 2024 (€ 67,627) Unfavourable step	▼ 54%
Equity	€ 257,763 Equity 2022: € 257,763 First fiscal year in the series	€ 257,792 Equity 2023: € 257,792 Unchanged (€ 257,763) Favourable step	€ 257,794 Equity 2024: € 257,794 Unchanged (€ 257,792) Favourable step	€ 29,196 Equity 2025: € 29,196 ▼ 89% vs 2024 (€ 257,794) Unfavourable step	▼ 89%
Total debts	€ 492,639 Total debts 2022: € 492,639 First fiscal year in the series	€ 330,410 Total debts 2023: € 330,410 ▼ 33% vs 2022 (€ 492,639) Favourable step	€ 385,123 Total debts 2024: € 385,123 ▲ 17% vs 2023 (€ 330,410) Unfavourable step	€ 509,066 Total debts 2025: € 509,066 ▲ 32% vs 2024 (€ 385,123) Unfavourable step	▲ 32%
Cash	€ 214,175 Cash 2022: € 214,175 First fiscal year in the series	€ 136,168 Cash 2023: € 136,168 ▼ 36% vs 2022 (€ 214,175) Unfavourable step	€ 117,104 Cash 2024: € 117,104 ▼ 14% vs 2023 (€ 136,168) Unfavourable step	€ 110,756 Cash 2025: € 110,756 ▼ 5% vs 2024 (€ 117,104) Unfavourable step	▼ 5%
Land & buildings	€ 56,365 Land & buildings 2022: € 56,365 First fiscal year in the series	€ 39,519 Land & buildings 2023: € 39,519 ▼ 30% vs 2022 (€ 56,365) Unchanged	€ 22,674 Land & buildings 2024: € 22,674 ▼ 43% vs 2023 (€ 39,519) Unchanged	€ 18,753 Land & buildings 2025: € 18,753 ▼ 17% vs 2024 (€ 22,674) Unchanged	▼ 17%
Retained profit	€ 239,163 Retained profit 2022: € 239,163 First fiscal year in the series	€ 239,192 Retained profit 2023: € 239,192 Unchanged (€ 239,163) Favourable step	€ 239,194 Retained profit 2024: € 239,194 Unchanged (€ 239,192) Favourable step	€ 10,596 Retained profit 2025: € 10,596 ▼ 96% vs 2024 (€ 239,194) Unfavourable step	▼ 96%
Dividend	€ 37,000 Dividend 2022: € 37,000 First fiscal year in the series	€ 57,950 Dividend 2023: € 57,950 ▲ 57% vs 2022 (€ 37,000) Unchanged	€ 67,625 Dividend 2024: € 67,625 ▲ 17% vs 2023 (€ 57,950) Unchanged	€ 259,725 Dividend 2025: € 259,725 ▲ 284% vs 2024 (€ 67,625) Unchanged	▲ 284%
Bank debt	€ 229,232 Bank debt 2022: € 229,232 First fiscal year in the series	€ 148,500 Bank debt 2023: € 148,500 ▼ 35% vs 2022 (€ 229,232) Favourable step	€ 117,340 Bank debt 2024: € 117,340 ▼ 21% vs 2023 (€ 148,500) Favourable step	€ 237,748 Bank debt 2025: € 237,748 ▲ 103% vs 2024 (€ 117,340) Unfavourable step	▲ 103%
Balance sheet total	€ 750,402 Balance sheet total 2022: € 750,402 First fiscal year in the series	€ 588,202 Balance sheet total 2023: € 588,202 ▼ 22% vs 2022 (€ 750,402) Unchanged	€ 642,918 Balance sheet total 2024: € 642,918 ▲ 9% vs 2023 (€ 588,202) Unchanged	€ 538,262 Balance sheet total 2025: € 538,262 ▼ 16% vs 2024 (€ 642,918) Unchanged	▼ 16%
Employees (FTE)	3.3 Employees (FTE) 2022: 3.3 First fiscal year in the series	3.3 Employees (FTE) 2023: 3.3 Unchanged (3.3) Unchanged	3.1 Employees (FTE) 2024: 3.1 ▼ 0.2 vs 2023 (3.3) Unchanged	2.7 Employees (FTE) 2025: 2.7 ▼ 0.4 vs 2024 (3.1) Unchanged	▼ 0.4

Key figures of APOTHEEK SLUIZEKEN GENT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK SLUIZEKEN GENT?

What happened at APOTHEEK SLUIZEKEN GENT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 9, 2026 New annual accounts for financial year 2025: profit of € 31,126 (▼ 54% vs 2024). Source: NBB ↗
2025 Malinga BV became a director. NBB
2025 Groep DF BV stepped down as director. NBB
2015 Groep DF BV became a director. NBB
Aug 17, 2011 New establishment in Gent. KBO
Aug 10, 2011 Start of the company according to the CBE. KBO